Sex inversion of sexually immature honeycomb grouper (Epinephelus merra) by aromatase inhibitor.
Previous studies have shown that estrogen plays an important role in sex change of protogynous honeycomb grouper, and that the treatments with aromatase inhibitor (AI) cause estrogen depletion and complete sex inversion of pre-spawning females into functional males. In the present study, we examined whether AI causes sex inversion of sexually immature females. Female honeycomb groupers were implanted with various doses of Fadrozole (0, 100, 500 and 1000 microg/fish) in the non-breeding season, and resultant changes in the gonadal structures and the plasma levels of sex steroid hormones (estradiol-17 beta, E2; testosterone, T; 11-ketotestosterone, 11-KT) were examined three months after implantation. Vehicle-implanted groups did not change sex, while 100 and 500 microg AI-implanted groups had turned into transitionals with intersex gonad. In contrast, the highest dose receiving group exhibited both transitional and male phases. Transitional phase gonad had atretic oocytes and spermatogenic germ cells at the late stages of spermatogenesis, while male phase testis contained spermatozoa accumulated in the seminiferous tubules. All males released sperm upon slight pressure on the abdomen. In the AI-implanted fish, plasma levels of E2 decreased in a dose-dependent manner, while the levels of 11-KT were high in the highest dose receiving group. Present results suggest that estrogen plays an important role in sex change of protogynous honeycomb grouper, and that treatments with AI potentially inhibits endogenous E2 production in vivo, causing oocyte degeneration and subsequently the sex inversion from female to male. The Fadrozole could be an important tool for manipulating the sex of hermaphrodite fishes.
Bhandari
Ramji Kumar
RK
Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus, Motobu, Okinawa, Japan.
Komuro
Hiroki
H
Higa
Mikihiko
M
Nakamura
Masaru
M
D000818:Animals; D047072:Aromatase Inhibitors; D004958:Estradiol / Q000378:metabolism; D017316:Fadrozole / Q000494:pharmacology*; D005260:Female; D057850:Hermaphroditic Organisms; D006652:Histological Techniques; D008297:Male; D009865:Oocytes / Q000166:cytology; D010473:Perciformes / Q000033:anatomy & histology / Q000502:physiology*; D019849:Sex Determination Processes; D012733:Sex Differentiation / Q000187:drug effects*; D013737:Testis / Q000033:anatomy & histology; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism
D047072:Aromatase Inhibitors; D013739:Testosterone; D004958:Estradiol; D017316:Fadrozole; C003600:11-ketotestosterone